Adma Biologics reported $272.2M in Market Capitalization this January of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Adamis Pharmaceuticals ADMP:US 0.14B 0.02B
Adma Biologics ADMA:US $ 0.15B 0.06B
Agile Therapeutics AGRX:US $ 0.09B 0.03B
Alnylam Pharmaceuticals ALNY:US $ 22.44B 2.51B
Antares Pharma ATRS:US $ 0.62B 0.12B
Biocryst Pharmaceuticals BCRX:US $ 2.57B 0.24B
China Cord Blood CO:US 0.57B 0.08B
Dynavax Technologies DVAX:US $ 2.2B 1.08B
Kindred Biosciences KIN:US $ 0.42B 0.2B
Minerva Neurosciences NERV:US $ 0.07B 0.02B
Novavax NVAX:US $ 15.44B 0.29B
Omeros OMER:US $ 0.86B 0.06B
Takeda 4502:JP 5852.75B 17.24B